8-31111657-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP3BP6

The NM_000553.6(WRN):​c.2131C>T​(p.Arg711Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000363 in 1,613,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R711Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 0 hom. )

Consequence

WRN
NM_000553.6 missense

Scores

6
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.17

Publications

14 publications found
Variant links:
Genes affected
WRN (HGNC:12791): (WRN RecQ like helicase) This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]
WRN Gene-Disease associations (from GenCC):
  • Werner syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • osteosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.828
BP6
Variant 8-31111657-C-T is Benign according to our data. Variant chr8-31111657-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 238136.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WRNNM_000553.6 linkc.2131C>T p.Arg711Trp missense_variant Exon 19 of 35 ENST00000298139.7 NP_000544.2 Q14191

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WRNENST00000298139.7 linkc.2131C>T p.Arg711Trp missense_variant Exon 19 of 35 1 NM_000553.6 ENSP00000298139.5 Q14191
WRNENST00000521620.5 linkn.764C>T non_coding_transcript_exon_variant Exon 7 of 23 1
WRNENST00000650667.1 linkn.*1745C>T non_coding_transcript_exon_variant Exon 18 of 34 ENSP00000498593.1 A0A494C0M3
WRNENST00000650667.1 linkn.*1745C>T 3_prime_UTR_variant Exon 18 of 34 ENSP00000498593.1 A0A494C0M3

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152086
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000231
AC:
58
AN:
251384
AF XY:
0.000169
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000382
AC:
558
AN:
1461732
Hom.:
0
Cov.:
31
AF XY:
0.000356
AC XY:
259
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33472
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39658
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86252
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53412
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5762
European-Non Finnish (NFE)
AF:
0.000476
AC:
529
AN:
1111938
Other (OTH)
AF:
0.000232
AC:
14
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.000134
AC XY:
10
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41528
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68000
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000329
Hom.:
0
Bravo
AF:
0.000181
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000222
AC:
27
EpiCase
AF:
0.000654
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 19, 2021
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNA sequence analysis of the WRN gene demonstrated a sequence change, c.2131C>T, in exon 19 that results in an amino acid change, p.Arg711Trp. This sequence change does not appear to have been previously described in individuals with WRN-related disorders. This sequence change has been described in the gnomAD database with a low frequency of 0.040% in the non-Finnish European subpopulation (dbSNP rs34560788). The p.Arg711Trp change affects a highly conserved amino acid residue located in a domain of the WRN protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg711Trp substitution. Due to insufficient evidence and the lack of functional studies, the clinical significance of the p.Arg711Trp change remains unknown at this time. -

not provided Uncertain:1
Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

WRN-related disorder Uncertain:1
Nov 10, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The WRN c.2131C>T variant is predicted to result in the amino acid substitution p.Arg711Trp. This variant was reported in a cohort study of patients with dyslipidemia and other metabolic phenotypes (Table S4, Dron et al 2020. PubMed ID: 32041611). This variant is reported in 0.040% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-30969173-C-T) and has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from likely benign to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/238136/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Werner syndrome Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.49
T
Eigen
Uncertain
0.64
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.062
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Benign
-0.88
T
MutationAssessor
Pathogenic
3.6
H
PhyloP100
2.2
PrimateAI
Benign
0.25
T
PROVEAN
Pathogenic
-7.3
D
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.73
MVP
0.72
MPC
0.40
ClinPred
0.74
D
GERP RS
4.3
Varity_R
0.92
gMVP
0.80
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34560788; hg19: chr8-30969173; COSMIC: COSV53306281; API